Systemic Lupus Erythematosus – Pipeline Assessment And Market Forecasts To 2017


Original Source: Rheumatoid Arthritis Market

Buy Now: Market Research

Browse all : Pharmaceuticals Market

GlobalData, the industry analysis specialists new report, Systemic Lupus Erythematosus – Pipeline Assessment and Market Forecasts to 2017 is an essential source of information and analysis on the global systemic lupus erythematosus market. The report identifies the key trends shaping and driving the global systemic lupus erythematosus market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global systemic lupus erythematosus sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalDatas team of industry experts

GlobalData estimated the Systemic Lupus Erythematosus (SLE) market to be worth $ 350 million in 2009 with a projected Compound Annual Growth Rate (CAGR) of 6% and projected market value to exceed $ 2.5 billion in 2017. Products for systemic lupus erythematosus in developmental pipeline are strong. The pipeline molecules have a distinct advantage over the currently used off-label marketed drugs. These molecules are primarily first-in-class molecules displaying the robustness of the systemic lupus erythematosus pipeline.

GlobalData finds that the launch of pipeline products may have a superior efficacy in overcoming with the currently marketed products. However, several compounds are in development, and it must be hoped that, many will bring significant relief to number of systemic lupus erythematosus patients in reducing the symptoms. With all these market constraints, the only rational outcome for the new launches would be to provide more safety profile and better efficacy, cost advantage to the market in systemic lupus erythematosus market.


The scope of the report includes:

Annualized global systemic lupus erythematosus market revenues data from 2001 to 2009, forecast forward for 8 years to 2017.

Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France and Japan.

Pipeline analysis data providing a split across different phases by mechanism of action being developed and emerging trends. Key classes of mechanism of action include T and B cell modulators, Immunomodulators, Hormonal Agents, phosphodiesterase type 4inhibitor, Anti Alpha INF, Interleukin inhibitors and anti CD antigens.

Analysis of the current and future market competition in the global systemic lupus erythematosus market. Key market players covered are F. Hoffmann-La Roche Ltd (Genentech) , MedImmune, Bristol-Myers Squibb, GlaxoSmithKline, Human Genome Sciences, UCB S.A, Amgen and Biogen Idec.

Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with systemic lupus erythematosus.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

Develop business strategies by understanding the trends shaping and driving the global systemic lupus erythematosus market.

Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global systemic lupus erythematosus market in future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Whats the next big thing in the global systemic lupus erythematosus market landscape? – Identify, understand and capitalize.

Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.
Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as pres